Biocartis Pushing Further Into Immunotherapy, Liquid Biopsy Space With Idylla Menu – GenomeWeb

Posted by on March 5, 2019 10:57 pm
Tags:
Categories: Crispr Articles

Source: Biocartis Pushing Further Into Immunotherapy, Liquid Biopsy Space With Idylla Menu – GenomeWeb

NEW YORK (GenomeWeb) – Biocartis is expanding into the oncology space with a planned series of immunotherapy and liquid biopsy assays on its flagship Idylla molecular testing platform.

The Belgian firm last week laid out plans for liquid biopsy panels for guiding therapy selection for cancer patients and monitoring therapy response, post-therapy minimal residual disease (MRD), and recurrence.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Published at Tue, 05 Mar 2019 18:45:30 +0000

< Immunotherapy Today home